@article{928e7d51457547908858cb759468ddd1,
title = "Prostate-specific Antigen Progression in Enzalutamide-treated Men with Nonmetastatic Castration-resistant Prostate Cancer: Any Rise in Prostate-specific Antigen May Require Closer Monitoring",
abstract = "While the majority of enzalutamide-treated patients with nonmetastatic castration-resistant prostate cancer in PROSPER had some increase from nadir in prostate-specific antigen at the time of radiographic progression, the median absolute increase was less than the Prostate Cancer Working Group 2 threshold of 2 ng/mL.",
keywords = "Enzalutamide, Nonmetastatic castration-resistant prostate cancer, Prostate Cancer Working Group 2, Prostate-specific antigen progression",
author = "Fred Saad and Sternberg, {Cora N.} and Eleni Efstathiou and Karim Fizazi and Katharina Modelska and Xun Lin and Jennifer Sugg and Joyce Steinberg and Bettina Noerby and Shore, {Neal D.} and Maha Hussain",
note = "Publisher Copyright: {\textcopyright} 2020 The Authors",
year = "2020",
month = dec,
day = "1",
doi = "10.1016/j.eururo.2020.08.025",
language = "English",
volume = "78",
pages = "847--853",
journal = "European Urology",
issn = "0302-2838",
number = "6",
}